Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Testosterone and chronic sildenafil/tadalafil anti-apoptotic role in aged diabetic rats

International Journal of Impotence Research volume 22, pages 255–261 (2010)Cite this article

Subjects

Abstract

This work aimed to assess the cavernous anti-apoptotic role of using chronic low-dose sildenafil/tadalafil with and without testosterone (T) in aged diabetic rats. In all, 140 Sprague-Dawley aged rats were divided into the following groups: controls; induced diabetic rats; diabetic rats that received intramuscular depot T once every 4 weeks; diabetic rats on sildenafil 2 mg kg–1 orally daily; diabetic rats on T and daily sildenafil; diabetic rats on tadalafil 0.45 mg kg–1 orally every other day; diabetic rats on every-other-day tadalafil and T; diabetic rats on alternate sildenafil and tadalafil; and diabetic rats on alternate sildenafil, tadalafil and T. After 12 weeks, Bax (apoptotic factor), Bcl2 (B-cell lymphoma 2; anti-apoptotic factor), cGMP (cyclic guanosine monophosphate) were estimated in their cavernous tissues. Compared with the controls, aged diabetic rats showed significant increased cavernous tissue Bax and significant decreased Bcl2, in which diabetic rats injected with T showed the reverse compared with the diabetic rats. Diabetic rats on sildenafil or tadalafil showed significant increased cavernous Bcl2 and decreased Bax with upgraded Bcl2/Bax ratio that was improved being on T. Diabetic rats on alternate sildenafil/tadalafil with or without T showed further significant increased cavernous tissue Bcl2 with upgraded Bcl2/Bax ratio. It is concluded that frequent low-dose use of sildenafil and/or tadalafil combined with T would be predicted to have a pronounced anti-apoptotic cavernous tissue effect on the cavernous tissues of aged diabetic rats.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Hetts SW . To die or not to die: an overview of apoptosis and its role in disease. JAMA 1998; 279: 300–307.

    Article  CAS  PubMed  Google Scholar 

  2. Fadeel B, Orrenius S . Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 2005; 258: 479–517.

    Article  CAS  PubMed  Google Scholar 

  3. Sinha Hikim AP, Swerdloff RS . Hormonal and genetic control of germ cell apoptosis in the testis. Rev Reprod 1999; 4: 38–47.

    Article  CAS  PubMed  Google Scholar 

  4. Ljunggren C, Hedelin H, Salomonsson K, Ströberg P . Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance. J Sex Med 2008; 5: 469–475.

    Article  PubMed  Google Scholar 

  5. Ghofrani HA, Osterloh IH, Grimminger F . Case history: Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 2006; 5: 689–702.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mostafa T . Oral phosphodiesterase-5 inhibitors: non-erectogenic beneficial uses. J Sex Med 2008; 5: 2502–2518.

    Article  CAS  PubMed  Google Scholar 

  7. Das A, Xi L, Kukreja RC . Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 2005; 280: 12944–12955.

    Article  CAS  PubMed  Google Scholar 

  8. Lee KW, Jeong JY, Lim BJ, Chang YK, Lee SJ, Na KR et al. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 2009; 257: 137–143.

    Article  CAS  PubMed  Google Scholar 

  9. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD . Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol 2008; 179: 779–785.

    Article  CAS  PubMed  Google Scholar 

  10. De Young LX, Domes T, Lim K, Carson J, Brock GB . Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats. Eur Urol 2008; 54: 213–220.

    Article  CAS  PubMed  Google Scholar 

  11. Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008; 20: 479–486.

    Article  CAS  PubMed  Google Scholar 

  12. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J et al. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008; 101: 203–210.

    CAS  PubMed  Google Scholar 

  13. Burchardt T, Burchardt M, Karden J, Buttyan R, Shabsigh A, de la Taille A et al. Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat. J Urol 2000; 164: 1807–1811.

    Article  CAS  PubMed  Google Scholar 

  14. Hwang TI, Lin YC . The relationship between hypogonadism and erectile dysfunction. Int J Impot Res 2008; 20: 231–235.

    Article  CAS  PubMed  Google Scholar 

  15. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H . Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2008; 179: S97–S102.

    CAS  PubMed  Google Scholar 

  16. Yassin AA, Saad F . Testosterone and erectile dysfunction. J Androl 2008; 29: 593–604.

    Article  CAS  PubMed  Google Scholar 

  17. Paget GE, Barnes GM . Evaluation of Drug Activities, Vol. 1. Academic Press: London, 1964; 135.

    Book  Google Scholar 

  18. Chomkczynski P, Sacchi N . Single step method for RNA isolation by the acid guanidinum thiocyanate-phenol-chloroform method. Anal Biochem 1987; 162: 156–160.

    Google Scholar 

  19. Abdel Aziz MT, Mostafa T, Atta H, Rashed L, Marzouk SA, Obaia EM et al. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues. J Sex Med 2008; 5: 1636–1645.

    Article  CAS  Google Scholar 

  20. Rao K, Liu JH . Cell apoptosis and male erectile dysfunction. Zhonghua Nan Ke Xue 2008; 14: 1126–1129.

    CAS  PubMed  Google Scholar 

  21. Alici B, Gümüstas MK, Ozkara H, Akkus E, Demirel G, Yencilek F et al. Apoptosis in the erectile tissues of diabetic and healthy rats. BJU Int 2000; 85: 326–329.

    Article  CAS  PubMed  Google Scholar 

  22. Liu J, Xia R, Fu W, Chen Y, Liu G . Apoptosis and hemodynamic changes of the penile tissue in diabetic rats. Zhonghua Nan Ke Xue 2004; 10: 445–448.

    CAS  PubMed  Google Scholar 

  23. Costa C, Soares R, Castela A, Adães S, Hastert V, Vendeira P et al. Increased endothelial apoptotic cell density in human diabetic erectile tissue—comparison with clinical data. J Sex Med 2009; 6: 826–835.

    Article  PubMed  Google Scholar 

  24. Malavige LS, Levy JC . Erectile dysfunction in diabetes mellitus. J Sex Med 2009; 6: 1232–1247.

    Article  PubMed  Google Scholar 

  25. Ryu JK, Kim DJ, Lee T, Kang YS, Yoon SM, Suh JK . The role of free radical in the pathogenesis of impotence in streptozotocin-induced diabetic rats. Yonsei Med J 2003; 44: 236–241.

    Article  CAS  PubMed  Google Scholar 

  26. Angulo J, Cuevas P, Fernandez A, Gabancho S, Allona A, Martin-Morales A et al. Activation and potentiation of NO/cGMP pathway by NG-hydroxyl-L-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and aging. Br J Pharmacol 2003; 138: 63–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007; 583 (Pt 1): 9–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wang D, Xie H, Wang G . Apoptosis and the expression of Bax and Bcl-2 in the penis of diabetic rats. Zhonghua Nan Ke Xue 2004; 10: 844–848.

    CAS  PubMed  Google Scholar 

  29. Seftel AD, Maclennan GT, Chen ZJ, Liu S, Ferguson K, Deoreo G et al. Loss of TGFbeta, apoptosis, and Bcl-2 in erectile dysfunction and upregulation of p53 and HIF-1alpha in diabetes-associated erectile dysfunction. Mol Urol 1999; 3: 103–107.

    CAS  PubMed  Google Scholar 

  30. Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC . Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 2005; 111: 1601–1610.

    Article  CAS  PubMed  Google Scholar 

  31. Salloum FN, Abbate A, Das A, Houser JE, Mudrick CA, Qureshi IZ et al. Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol 2008; 294: H1398–H1406.

    Article  CAS  PubMed  Google Scholar 

  32. Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer YA et al. Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vascul Pharmacol 2005; 42: 219–232.

    Article  CAS  PubMed  Google Scholar 

  33. Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J et al. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol Reprod 2007; 76: 915–923.

    Article  CAS  PubMed  Google Scholar 

  34. Buvat J, van Ahlen H, Schmitt H, Chan M, Kuepfer C, Varanese L . Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries. J Sex Med 2006; 3: 512–520.

    Article  CAS  PubMed  Google Scholar 

  35. Ebrahimi F, Shafaroodi H, Asadi S, Nezami BG, Ghasemi M, Rahimpour S et al. Sildenafil decreased cardiac cell apoptosis in diabetic mice: reduction of oxidative stress as a possible mechanism. Can J Physiol Pharmacol 2009; 87: 556–564.

    Article  CAS  PubMed  Google Scholar 

  36. Caretti A, Bianciardi P, Ronchi R, Fantacci M, Guazzi M, Samaja M . Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of hypoxia-inducible factor-1alpha signaling. Exp Biol Med (Maywood) 2008; 233: 1222–1230.

    Article  CAS  Google Scholar 

  37. Ebrahimi F, Shafaroodi H, Asadi S, Nezami BG, Ghasemi M, Rahimpour S et al. Sildenafil decreased cardiac cell apoptosis in diabetic mice: reduction of oxidative stress as a possible mechanism. Can J Physiol Pharmacol 2009; 87: 556–564.

    Article  CAS  PubMed  Google Scholar 

  38. Tam NN, Gao Y, Leung YK, Ho SM . Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 2003; 163: 2513–2522.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Tenover JS . Prevalence and management of mild hypogonadism: introduction. Int J Impot Res 2003; 15 (Suppl 4): S1–S2.

    Article  PubMed  Google Scholar 

  40. Kalinchenko SY, Kozlov GI, Gontcharov NP, Katsiya GV . Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male 2003; 6: 94–99.

    Article  CAS  PubMed  Google Scholar 

  41. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A . Androgens improve cavernous vasodilatation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 2003; 58: 632–638.

    Article  CAS  Google Scholar 

  42. Gooren LJ, Saad F . Recent insights into androgen action on the anatomical and physiological substrate of penile erection. Asian J Androl 2006; 8: 3–9.

    Article  CAS  PubMed  Google Scholar 

  43. Park K, Ryu KS, Li WJ, Kim SW, Paick JS . Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction. Eur Urol 2008; 53: 1282–1288.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Andrology and Sexology, Faculty of Medicine, Cairo University, Cairo, Egypt

    T Mostafa & K Kotb

  2. Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Cairo, Egypt

    L A Rashed

Authors
  1. T Mostafa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L A Rashed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Kotb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T Mostafa.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mostafa, T., Rashed, L. & Kotb, K. Testosterone and chronic sildenafil/tadalafil anti-apoptotic role in aged diabetic rats. Int J Impot Res 22, 255–261 (2010). https://doi.org/10.1038/ijir.2010.12

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2010.12

Keywords

This article is cited by

Search

Advanced search

Quick links